• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Anixa Biosciences Inc (NQ: ANIX )

    2.690 -0.040 (-1.47%)
    Streaming Delayed Price Updated: 11:59 AM EDT, May 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 68,356
    Open 2.700
    Bid (Size) 2.690 (79)
    Ask (Size) 2.710 (2)
    Prev. Close 2.730
    Today's Range 2.640 - 2.770
    52wk Range 2.700 - 5.130
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Anixa Biosciences, Inc. (NASDAQ: ANIX) Featured in Coverage of the EF Hutton Annual Global Conference
    Via Investor Brand Network
    Sidoti Events, LLC's Virtual May Micro-Cap Conference
    Via ACCESSWIRE

    Performance

    YTD
    -31.55%
    -31.55%
    1 Month
    -10.63%
    -10.63%
    3 Month
    -30.31%
    -30.31%
    6 Month
    -7.24%
    -7.24%
    1 Year
    -21.11%
    -21.11%

    More News

    Read More
    Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
    Via AB Newswire
    Recap: Anixa Biosciences Q1 Earnings
    Via Benzinga
    Sidoti Events, LLC's Virtual January Micro-Cap Conference
    Via ACCESSWIRE
    6 Analysts Have This to Say About Anixa Biosciences
    Via Benzinga
    Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape?
    Via Benzinga
    3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023
    Via InvestorPlace
    Anixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says 'Exceeded Expectations'
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    The 3 Most Undervalued Cheap Stocks to Buy in September 2023
    Via InvestorPlace
    The Latest Analyst Ratings for Anixa Biosciences
    Via Benzinga
    Expert Ratings for Anixa Biosciences
    Via Benzinga
    Could Anixa Biosciences (NASDAQ:ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
    Via ACCESSWIRE
    Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
    Via Benzinga
    Anixa Biosciences And 2 Other Penny Stocks Insiders Are Aggressively Buying
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Appreciating The Passing Of A Titan & Incorporating Alternative Data Signals
    Via Talk Markets
    Benzinga's Top Ratings Upgrades, Downgrades For December 23, 2022
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
    Via Benzinga
    Recap Of Monday's Biotech Catalysts - End Of the Day Summary
    Via Benzinga
    Anixa Initiates Patient Dosing in Initial-Stage Ovarian Cancer Study
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.